26364-65-8Relevant articles and documents
MLKL INHIBITORS
-
Paragraph 0997-0999, (2018/09/26)
Purine derivatives that inhibit cellular necroptosis and/or human MLKL, pharmaceutical compositions thereof, and methods of treating an MLKL-mediated disorder with an effective amount of the compound or composition. Said MLKL-mediated disorder is pathology associated necroptosis, including ischemia-reperfusion damage, neurodegeneration, and inflammatory diseases such as acute pancreatitis, multiple sclerosis, inflammatory bowel disease, and allergic colitis.
An antibiotic anticancer activity method for the preparation of compounds
-
Paragraph 0051; 0052; 0061, (2018/07/10)
The invention discloses a preparation method of an antibacterial anti-cancer active compound. The preparation method comprises the following steps: under cooling in an ice bath, enabling a compound HRB-1365-0, a compound HRB-1365-1 and water to react at a
PROCESS FOR PREPARING CYANIMINO-1,3-THIAZOLIDINES
-
Page/Page column 5, (2009/04/25)
The present invention relates to a process for preparing cyanimino-1,3-thiazolidines, which are important building blocks for the preparation of crop protection active ingredients and pharmaceuticals, by the following scheme: where A is an alkali metal an